The new facility, called the Manchester Centre for Integrative Systems Biology, will use this money "to develop new methods of computational and mathematical analysis, validating these methods by testing them in yeast."
These methods will then be used to "create generic computational models with the potential to allow pharmaceutical companies to perform virtual trials of any medicine on any living organism," the university said.
The award was provided by The Biotechnology and Biological Sciences Research Council.
"Our aim is to develop the systems which will allow University scientists and pharmaceutical companies to understand how every gene in an organism works and reacts," said Douglas Kell, director of the new center. "This will provide them with the tools they need to develop safer and more effective medicines and will put Manchester on the map as one of the world centers for systems biology research."
It was not immediately clear when the new center will open.